Copeland Capital Management LLC Reduces Holdings in U.S. Physical Therapy, Inc. $USPH

Copeland Capital Management LLC reduced its holdings in shares of U.S. Physical Therapy, Inc. (NYSE:USPH) by 6.9% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 786,114 shares of the company’s stock after selling 57,867 shares during the quarter. U.S. Physical Therapy makes up 1.4% of Copeland Capital Management LLC’s investment portfolio, making the stock its 19th largest position. Copeland Capital Management LLC owned approximately 0.05% of U.S. Physical Therapy worth $61,388,000 as of its most recent SEC filing.

Other hedge funds have also recently added to or reduced their stakes in the company. Advisory Services Network LLC purchased a new position in U.S. Physical Therapy during the 3rd quarter valued at about $39,000. EverSource Wealth Advisors LLC increased its holdings in U.S. Physical Therapy by 68.8% during the 3rd quarter. EverSource Wealth Advisors LLC now owns 471 shares of the company’s stock valued at $40,000 after acquiring an additional 192 shares in the last quarter. GAMMA Investing LLC increased its holdings in U.S. Physical Therapy by 207.1% during the 4th quarter. GAMMA Investing LLC now owns 516 shares of the company’s stock valued at $40,000 after acquiring an additional 348 shares in the last quarter. iSAM Funds UK Ltd purchased a new position in U.S. Physical Therapy during the 3rd quarter valued at about $52,000. Finally, Blue Trust Inc. increased its holdings in U.S. Physical Therapy by 35.3% during the 3rd quarter. Blue Trust Inc. now owns 640 shares of the company’s stock valued at $54,000 after acquiring an additional 167 shares in the last quarter.

U.S. Physical Therapy Stock Performance

Shares of NYSE USPH opened at $74.91 on Friday. The company has a market cap of $1.13 billion, a PE ratio of 52.75, a price-to-earnings-growth ratio of 2.00 and a beta of 1.35. U.S. Physical Therapy, Inc. has a 12 month low of $66.67 and a 12 month high of $93.50. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.01 and a quick ratio of 1.01. The company has a 50-day simple moving average of $78.59 and a 200-day simple moving average of $80.72.

U.S. Physical Therapy (NYSE:USPH) last issued its quarterly earnings results on Thursday, February 26th. The company reported $0.67 EPS for the quarter, hitting analysts’ consensus estimates of $0.67. The business had revenue of $202.73 million during the quarter, compared to the consensus estimate of $200.10 million. U.S. Physical Therapy had a net margin of 5.07% and a return on equity of 8.75%. The company’s quarterly revenue was up 12.3% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.51 earnings per share. On average, equities analysts anticipate that U.S. Physical Therapy, Inc. will post 2.87 earnings per share for the current year.

U.S. Physical Therapy Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, April 10th. Stockholders of record on Friday, March 13th were issued a dividend of $0.46 per share. This represents a $1.84 dividend on an annualized basis and a dividend yield of 2.5%. This is a boost from U.S. Physical Therapy’s previous quarterly dividend of $0.45. The ex-dividend date was Friday, March 13th. U.S. Physical Therapy’s payout ratio is presently 129.58%.

Insider Transactions at U.S. Physical Therapy

In other news, COO Graham D. Reeve sold 662 shares of U.S. Physical Therapy stock in a transaction dated Wednesday, March 11th. The shares were sold at an average price of $78.86, for a total transaction of $52,205.32. Following the completion of the sale, the chief operating officer directly owned 30,078 shares in the company, valued at $2,371,951.08. The trade was a 2.15% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, EVP Richard Binstein sold 3,000 shares of U.S. Physical Therapy stock in a transaction dated Friday, March 6th. The stock was sold at an average price of $81.64, for a total transaction of $244,920.00. Following the sale, the executive vice president owned 24,867 shares of the company’s stock, valued at approximately $2,030,141.88. This trade represents a 10.77% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders own 2.00% of the company’s stock.

Analyst Ratings Changes

Several research firms have weighed in on USPH. Barrington Research restated an “outperform” rating and set a $103.00 target price on shares of U.S. Physical Therapy in a report on Friday, February 20th. Jefferies Financial Group upgraded shares of U.S. Physical Therapy to a “strong-buy” rating in a report on Thursday, March 12th. Finally, Weiss Ratings restated a “hold (c)” rating on shares of U.S. Physical Therapy in a report on Wednesday, January 21st. One research analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and two have issued a Hold rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $101.67.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc (NYSE: USPH) is a leading owner and operator of outpatient physical therapy clinics across the United States. The company delivers rehabilitative care to patients recovering from orthopedic injuries, neurological disorders and chronic conditions. Its core services include one-on-one physical therapy sessions, aquatic therapy, occupational therapy, massage therapy and sports medicine programs designed to restore mobility and enhance quality of life.

In addition to traditional rehabilitation services, U.S.